|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168 SEK | +5.79% |
|
+3.00% | +25.65% |
| 04-25 | Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| 04-25 | Biotage AB Approves a Dividend, Payable on May 3, 2024 | CI |
Biotage AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 384 million compared to SEK 341 million a year ago. Net income was SEK 74 million compared to SEK 46 million a year ago.
Basic earnings per share from continuing operations was SEK 1.12 compared to SEK 0.69 a year ago. Diluted earnings per share from continuing operations was SEK 1.11 compared to SEK 0.69 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +25.65% | 1.28B | |
| -30.79% | 15.65B | |
| -57.58% | 2.09B | |
| +19.25% | 1.88B | |
| -18.17% | 1.36B | |
| +2.06% | 798M | |
| -33.66% | 762M | |
| -36.55% | 724M | |
| -30.00% | 586M | |
| -17.85% | 268M |
BIOTAGE AB 
